Selbyville, Delaware, Market Study Report LLC recently added a new title on 2020-2027 Global Hormone Replacement Therapy Market Report from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2027.

Global Hormone Replacement Therapy Market to reach USD 46.24 billion by 2027. Global Hormone Replacement Therapy Market is valued approximately USD 31.06billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2020-2027.

Request a Sample Report of Hormone Replacement Therapy Market at:

Hormone replacement therapy (HRT) is hormone replacement therapy for natural hormones when the body does not produce enough hormones. For instance, thyroid patients and human growth hormone patients take hormone replacement therapy. In addition, HRT has been widely administered to menopausal women for the relief of symptoms such as hot flushes, night sweats, sleep disturbances, psychological and genito-urinary problems, and for the prevention of osteoporosis.

In addition, as per National Heart, Lung, and Blood the study of 2,000 American women, aged 30 to 60, found that in 2019, almost 47 percent of the population experienced the effects of a hormonal imbalance. Further, the key factors contributing to the growth of the global demand for hormone replacement therapy include growing the prevalence of menopausal disorders and rising consciousness among women about postmenopausal problems. Even as per NCBI in Nov 2020, approximately 1.3 million women undergo menopausal transition every year in the United States. It usually begins between the ages of 51 and 52.

However, about 5% of women experience early menopause between the ages of 40 and 45. Furthermore, new hormone replacement therapy releases are projected to substantially contribute to the growth of the hormone replacement therapy industry. However, the high cost of treatment impedes the growth of the market over the forecast period of 2020-2027. Also, it is expected that the advent of bioidentical hormone replacement therapy and the use of telemedicine for hormone replacement therapy would provide a rewarding opportunity to broaden the global demand for hormone replacement therapy.

Major market player included in this report are:

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd. (Genentech, Inc.)
  • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • Merck KGaA
  • Mylan N.V. (Viatris Inc.)
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer Inc.

The regional analysis of global Hormone Replacement Therapy market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North American is the leading/significant region across the world in terms of market share owing to Increase in producers’ releases of different generic hormone replacement therapy drugs, increase in target population and advances in drug delivery technologies, along with the production of new formulations. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as increased awareness of hormone replacement therapy, an unprecedented rise in the incidence of diabetes, and increased focus by healthcare providers in China, India, and Japan on reducing hormone deficiencies would create lucrative growth prospects for the Hormone Replacement Therapy market across Asia-Pacific region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Therapy Type:

Estrogen Hormone Replacement Therapy

Human Growth Hormone Replacement Therapy

Thyroid Hormone Replacement Therapy

Testosterone Hormone Replacement Therapy

Progestogen Hormone Replacement Therapy

By Route of Administration:




By Indication:



Male Hypogonadism

Growth Hormone Deficiency



  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

For More Details on Hormone Replacement Therapy Market Report at:

About Us:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975


Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]

Web site:


Leave a comment

Your email address will not be published. Required fields are marked *